The Vital Role of Vitamin D
Vitamin D is a nutrient that the body needs to maintain overall good health. Here are nine reasons why vitamin D plays a vital role in your health.
The Benefits of Drinking Tea
Tea comes in four varieties and can provide a host of health benefits. Here are some of the potential health benefits of drinking tea.
Hard Facts About Soft Drinks
Soft drinks are extremely popular beverages among both children and adults in the US. They are far from healthy, however.
Breast Cancer Survivors Battling Brittle Bones
Breast cancer survivors can have ongoing health challenges after they’ve beaten "The Big C." Many are on medications that block estrogen, the hormone that drives most breast cancers. These medicines also increase the risk of osteoporosis (brittle bones) and increase the risk of fractures.
Material "Wood" Replace Damaged or Lost Bone
Remember the images of pirates scraping by with a wood leg? Well, wood may be coming back into fashion for repairing and replacing damaged bones.
FDA Issues Warning on Natural Supplement
There are countless dietary supplements marketed as natural remedies for pain relief. In some instances, these supplements turn out to be neither natural nor safe, which seems to be the case for Reumofan Plus.
FDA Issues Alert on Reumofan Plus
The U.S. Food and Drug Administration is warning consumers that Reumofan Plus, marketed as a “natural” dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not listed on the label that could be harmful.
Breaking News on Bone Drugs
They're designed to strengthen bones. This class of drugs known as bisphosphorates is also prescribed to cancer patients to treat excessive calcium in the blood. These drugs can actually increase the risks of unusual bone fractures.
Risks of a Life-Saving Surgery for Women
Women at risk of ovarian cancer are sometimes encouraged to get their ovaries removed. While ovary removal surgery can save a woman's life, it also may raise the risk of other health problems.
FDA Approves Prolia for osteoporosis
On September 16, 2011, the U.S. Food and Drug Administration granted approval for denosumab ( Prolia , Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.